VA to cov­er Ei­sai's new Alzheimer's drug af­ter de­clin­ing to cov­er Aduhelm

The Vet­er­ans Health Ad­min­is­tra­tion will cov­er Ei­sai and Bio­gen’s new Alzheimer’s drug Leqem­bi (lecanemab), re­vers­ing on an ear­li­er de­ci­sion to not pay for vet­er­ans to …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER